The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference41 articles.
1. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry;Fonarow;J Am Coll Cardiol,2007
2. Epidemiology and clinical course of heart failure with preserved ejection fraction;Lam;Eur J Heart Fail,2011
3. Outcome of heart failure with preserved ejection fraction in a population-based study;Bhatia;N Engl J Med,2006
4. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;N Engl J Med,2006
5. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients;Solomon;Circulation,2005
Cited by 956 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy;Journal of Molecular and Cellular Cardiology Plus;2024-03
2. From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk;Physiology;2024-03-01
3. The Angiotensin II Receptor Neprilysin Inhibitor LCZ696 Inhibits the NLRP3 Inflammasome By Reducing Mitochondrial Dysfunction in Macrophages and Alleviates Dextran Sulfate Sodium-induced Colitis in a Mouse Model;Inflammation;2024-02-06
4. Effects of exercise training on cardiac output in subjects with heart failure with preserved ejection fraction (HFpEF) – a protocol for a systematic review and meta-analysis;2024-02-05
5. Effect of sacubitril/valsartan on sinus rhythm maintenance after catheter ablation in patients with persistent atrial fibrillation without reduced ejection fraction heart failure: a study protocol for a multi-center, open-label, randomized, controlled, superiority clinical trial;Frontiers in Cardiovascular Medicine;2024-01-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3